Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Oncol (R Coll Radiol) ; 35(11): 744-755, 2023 11.
Article in English | MEDLINE | ID: mdl-37679230

ABSTRACT

AIMS: The role of metformin on the radiosensitising effect of cisplatin is not clear. Here we investigated the radiosensitising effect of metformin alone and combined with cisplatin in HeLa cells, as well as the implications of the adenosine monophosphate-activated protein kinase (AMPK) pathway on the radiosensitising effect. MATERIALS AND METHODS: HeLa cells were treated with ionising radiation, metformin, cisplatin, A769662 (AMPK activator) and dorsomorphin (AMPK inhibitor) or in combination. A cell proliferation assay, Western blot and flow cytometry were carried out. RESULTS: Metformin potentiated cisplatin cytotoxicity when administered 4 h before ionising radiation. Although the radiosensitising effects of metformin and cisplatin alone were observed, which is more apparent at high ionising radiation doses, the metformin-cisplatin combination did not increase the radiosensitivity of cisplatin at any ionising radiation dose. Dorsomorphin alone significantly decreased cell proliferation and potentiated the radiosensitising effects of cisplatin with ionising radiation. Administration of A769662 24 h prior to cisplatin treatment resulted in an increased AMPK level that yielded resistance to cisplatin, but this effect was not observed in HeLa cells concomitantly treated with A769662 and cisplatin. CONCLUSIONS: Modulation of AMPK may have a role in cervical cancer treatment. Increased AMPK levels result in higher sensitivity to ionising radiation but causes resistance to cisplatin. Dorsomorphin is proven to be a potent radiosensitising agent. The use of metformin alone may be an option as a radiosensitiser during high-dose ionising radiation (e.g. intracavitary brachytherapy).


Subject(s)
Lung Neoplasms , Metformin , Uterine Cervical Neoplasms , Female , Humans , Cisplatin/pharmacology , Metformin/pharmacology , Metformin/therapeutic use , AMP-Activated Protein Kinases/metabolism , AMP-Activated Protein Kinases/pharmacology , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/radiotherapy , HeLa Cells , Apoptosis , Lung Neoplasms/radiotherapy , Chemoradiotherapy , Cell Line, Tumor
2.
Analyst ; 141(4): 1405-12, 2016 Feb 21.
Article in English | MEDLINE | ID: mdl-26796951

ABSTRACT

The aim of this work is to evaluate whether the size of the analyte used as template for the synthesis of molecularly imprinted polymer nanoparticles (nanoMIPs) can affect their performance in pseudo-enzyme linked immunosorbent assays (pseudo-ELISAs). Successful demonstration of a nanoMIPs-based pseudo-ELISA for vancomycin (1449.3 g mol(-1)) was demonstrated earlier. In the present investigation, the following analytes were selected: horseradish peroxidase (HRP, 44 kDa), cytochrome C (Cyt C, 12 kDa) biotin (244.31 g mol(-1)) and melamine (126.12 g mol(-1)). NanoMIPs with a similar composition for all analytes were synthesised by persulfate-initiated polymerisation in water. In addition, core-shell nanoMIPs coated with polyethylene glycol (PEG) and imprinted for melamine were produced in organics and tested. The polymerisation of the nanoparticles was done using a solid-phase approach with the correspondent template immobilised on glass beads. The performance of the nanoMIPs used as replacement for antibodies in direct pseudo-ELISA (for the enzymes) and competitive pseudo-ELISA for the smaller analytes was investigated. For the competitive mode we rely on competition for the binding to the nanoparticles between free analyte and corresponding analyte-HRP conjugate. The results revealed that the best performances were obtained for nanoMIPs synthesised in aqueous media for the larger analytes. In addition, this approach was successful for biotin but completely failed for the smallest template melamine. This problem was solved using nanoMIP prepared by UV polymerisation in an organic media with a PEG shell. This study demonstrates that the preparation of nanoMIP by solid-phase approach can produce material with high affinity and potential to replace antibodies in ELISA tests for both large and small analytes. This makes this technology versatile and applicable to practically any target analyte and diagnostic field.


Subject(s)
Enzyme-Linked Immunosorbent Assay/methods , Molecular Imprinting , Nanoparticles , Polymers/chemistry , Polymers/chemical synthesis , Antibodies/immunology
3.
Opt Lett ; 26(6): 346-8, 2001 Mar 15.
Article in English | MEDLINE | ID: mdl-18040319

ABSTRACT

Lasing characteristics of dye-doped spherical solid microparticles produced by photopolymerization in aerosols are investigated. It is well known that dielectric spherical microparticles are optical resonators with very high quality. The resonant internal field is not completely confined to the interior of the particle. An evanescent wave extends a couple of micrometers into the surrounding area. This evanescent field decays exponentially. We demonstrate that cascade lasing can be excited by coupling of two spherical microresonators through this evanescent field.

SELECTION OF CITATIONS
SEARCH DETAIL
...